創益生技股份有限公司

Banner Up

Introduction

Chuang Yi Biotech (CYBiotech) specializes in researching and developing, and marketing of self-paid medicines and health foods that improves the customer's quality of life (QOL). The current Taiwan National Health Insurance have focused its resource in treating sever diseases such as cancer and infections. The insurance policy will gradually stop subsidizing non-life threatening medication in the future, where the patients will have to cover the cost of those non-life threatening medications. The general public's awareness of preventative medicine for the improvement of QOL has also been on the rise in recent years (e.g., obesity, diabetes prevention, erectile dysfunction, anti-aging, allergies and autoimmune remedies, and digestive health). With the aforementioned motivations, CYBiotech is aimed to provide the public with innovative medicine and health foods with the highest quality and efficiency through the principles of evidence based medicine. It is our purpose to fulfil the public's health care needs for improving their QOL.

Our Vision

CYB is committed to being the innovation leader in the field of self-paid medicines and health foods to improve quailty of life(QOL) among the regin of Taiwan and Greater China.

Our Mission

  1. Continuously research and develop self-paid products for a wide range of indications with high efficacy (new molecular entity in Taiwan, new indications for marketed drugs, new combination, new formulations)
  2. Uphold the spirit of evidence-based positioning the products by sustained clinical trials and regulatory registration.
  3. Deeply cultivate in medical channels and be the strategic partner with international pharmaceutical companies in Taiwan and the Greater China region.